Transgenic mice expressing the G0 or G2 alleles of APOL1 in podocytes under control of the nephrin promoter do not develop kidney disease (103) but mice expressing the G2 but not the G0 allele in podocytes under control of the podocin promoter developed FSGS lesions (48). This evidence concerns the gene APOL1 and kidney disorder.